These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 15553734)

  • 21. Effect of methotrexate sorbed on modified 2-hydroxyethylmethacrylate carriers in mice of C3H strain with a solid Gardner lymphosarcoma.
    Motycka K; Slavík ; kocovská A; Cihar R; Spacek P; Kubín M
    Neoplasma; 1977; 24(3):271-6. PubMed ID: 578291
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of protein as a carrier of methotrexate for experimental cancer chemotherapy. II. Chemotherapy of Gardner lymphosarcoma with pea seed lectin-methotrexate derivative.
    Bures L; Motycka K; Bostík J; Slavík K; Jirásek A
    Neoplasma; 1986; 33(4):409-16. PubMed ID: 3762803
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The chemotherapy of C3H mice bearing Gardner lymphosarcoma with bovine fibrinogen-methotrexate derivative.
    Motycka K; Slavík K; Dyr JE; Balcarová A; Vodrázka Z
    Neoplasma; 1981; 28(1):3-10. PubMed ID: 6895104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ag-specific type 1 CD8 effector cells enhance methotrexate-mediated antitumor responses by modulating differentiated T cell localization, activation and chemokine production in established breast cancer.
    Dobrzanski MJ; Reome JB; Hylind JC; Rewers-Felkins KA; Abulsamad K; Adams SL
    Clin Immunol; 2008 Aug; 128(2):205-18. PubMed ID: 18511346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intralesional methotrexate treatment for keratoacanthoma tumors: a retrospective study and review of the literature.
    Annest NM; VanBeek MJ; Arpey CJ; Whitaker DC
    J Am Acad Dermatol; 2007 Jun; 56(6):989-93. PubMed ID: 17504715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retention of tritiated methotrexate in a transplantable mouse glioma.
    Tator CH
    Cancer Res; 1976 Sep; 36(9 pt.1):3058-66. PubMed ID: 975073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application of anti-methotrexate Fab fragments for the optimization of intraperitoneal methotrexate therapy in a murine model of peritoneal cancer.
    Lobo ED; Balthasar JP
    J Pharm Sci; 2005 Sep; 94(9):1957-64. PubMed ID: 16052545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adsorption of methotrexate and calcium leucovorin onto cholestyramine in vitro.
    Merino-Sanjuán M; Carrera A; Monte E; Jiménez-Torres NV
    Int J Pharm; 2004 Jul; 278(2):283-91. PubMed ID: 15196633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
    Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Fundamental studies on the properties of a new adriamycin delivery system involving adsorption to activated carbon particles].
    Kawa J; Taniguchi H; Maeda T; Hagiwara A; Yamaguchi T; Takahashi T
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):606-10. PubMed ID: 3827257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Delayed clearance of methotrexate in a patient with malignant lymphoma who developed renal failure].
    Wakita A; Komatsu H; Banno S; Nitta M; Nagai H; Uchida T; Murase T; Nakahara Y; Tanaka M
    Gan To Kagaku Ryoho; 1995 Feb; 22(2):285-8. PubMed ID: 7857106
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic potential of 5-[125I]iodo-2'-deoxyuridine and methotrexate in the treatment of advanced neoplastic meningitis.
    Kassis AI; Kirichian AM; Wang K; Semnani ES; Adelstein SJ
    Int J Radiat Biol; 2004; 80(11-12):941-6. PubMed ID: 15764406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ag-specific type 1 CD8 effector cells enhance methotrexate-mediated antitumor responses by modulating endogenous CD49b-expressing CD4 and CD8 T effector cell subpopulations producing IL-10.
    Dobrzanski MJ; Reome JB; Hylind JC; Rewers-Felkins KA; Abdulsamad K; Adams SL
    Immunol Invest; 2008; 37(4):315-38. PubMed ID: 18569073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced pulmonary toxicity of peplomycin in a new drug-delivery system.
    Hagiwara A; Takahashi T; Ueda T; Torii T
    Anticancer Drug Des; 1988 Mar; 2(4):319-24. PubMed ID: 2452644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contributions of mucosal immune cells to methotrexate-induced mucositis.
    de Koning BA; van Dieren JM; Lindenbergh-Kortleve DJ; van der Sluis M; Matsumoto T; Yamaguchi K; Einerhand AW; Samsom JN; Pieters R; Nieuwenhuis EE
    Int Immunol; 2006 Jun; 18(6):941-9. PubMed ID: 16636014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. pH-sensitive pullulan-based nanoparticle carrier of methotrexate and combretastatin A4 for the combination therapy against hepatocellular carcinoma.
    Wang Y; Chen H; Liu Y; Wu J; Zhou P; Wang Y; Li R; Yang X; Zhang N
    Biomaterials; 2013 Sep; 34(29):7181-90. PubMed ID: 23791500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Chiral selectivity in differentiation of lung cancer A549 cell to vascular endothelial cells after drug resistance induced by D-or L-methotrexate enantiomers].
    He XD; Hu SL; Shen ZJ; Tao SN; Dong L; Zhu YY; Li M
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):690-4. PubMed ID: 19595065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute treatment with methotrexate induces hippocampal dysfunction in a mouse model of breast cancer.
    Yang M; Kim JS; Kim J; Jang S; Kim SH; Kim JC; Shin T; Wang H; Moon C
    Brain Res Bull; 2012 Oct; 89(1-2):50-6. PubMed ID: 22796103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo evaluation of a new polymer-lipid hybrid nanoparticle (PLN) formulation of doxorubicin in a murine solid tumor model.
    Wong HL; Rauth AM; Bendayan R; Wu XY
    Eur J Pharm Biopharm; 2007 Mar; 65(3):300-8. PubMed ID: 17156986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glucarpidase (carboxypeptidase g2) intervention in adult and elderly cancer patients with renal dysfunction and delayed methotrexate elimination after high-dose methotrexate therapy.
    Schwartz S; Borner K; Müller K; Martus P; Fischer L; Korfel A; Auton T; Thiel E
    Oncologist; 2007 Nov; 12(11):1299-308. PubMed ID: 18055849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.